Skip to main content

This job has expired

You will need to login before you can apply for a job.

Temporary Research Associate, Immuno-Oncology Research

Employer
Five Prime Therapeutics, Inc.
Location
South San Francisco, CA, United States
Start date
Sep 6, 2019

View more

Discipline
Science/R&D, Bioengineering, Research
Required Education
Bachelors Degree
Position Type
Full time
Hotbed
Biotech Bay

Job Details

Company Description

Five Prime Therapeutics, Inc. (NASDAQ: FPRX) is a publicly traded, clinical-stage biotechnology company focused on discovering and developing innovative immuno-oncology protein therapeutics to improve the lives of patients with serious diseases. Our industry-leading drug discovery platform, which includes comprehensive proprietary libraries of the extracellular proteome and differentiated screening capabilities, has led to a pipeline comprising five development programs in clinical trials across multiple indications in 2019. We also have several undisclosed research programs that have the potential to yield our next wave of development-stage therapeutic biologics. And we continue to fuel this process using our proprietary screens to discover new immuno-oncology targets.

Five Prime is committed to innovation and outstanding science to develop effective new drugs for the treatment of severe diseases. We value our culture of openness, collaboration and productivity. Discover more about FivePrime at www.fiveprime.com.

Job Description

We are currently seeking a highly motivated and innovative Research Associate to join our Immuno-Oncology group in a temporary full-time position. The successful candidate will join a team identifying and validating novel cancer immune therapeutics. This individual will undertake activities such as antibody screening, assay development and exploration of mechanisms of action to progress targets from Discovery to IND-enabling studies. Drug development experience is preferred and the ideal candidate will have experience working in a cross-functional team setting. This is a temporary full-time position for six months with the potential for extension to one year.

Responsibilities:
  • Perform in vitro assays and collaborate with the pharmacology group to dissect the mechanism of action for preclinical therapeutic molecules targeting T cells.
  • Perform in vitro assays to guide selection of candidate molecules with the desired pharmacologic properties.
  • Collaborate with the other scientists/ project leads on assigned projects.
  • Execute experiments and scientific tasks with independence, scientific rigor and curiosity.

Qualifications

  • B.S or M.S in Life sciences, Biology, Immunology, Pharmacology or related field with 3+ years of relevant research experience. The ideal candidate will have experience in the biopharmaceutical industry.
  • Experience with multiparameter flow cytometry, gene expression and cell transfection methods, primary immune cell assays and immunological read-outs is required.
  • Expertise in multiparameter flow cytometry including cell sorting is highly desired.
  • Experience executing a therapeutic antibody screen, including approaches to automate / execute assays in a high through-put manner, is highly desired.
  • Experience with biochemical assays to evaluate receptor engagement and proximal signaling cascades is highly desired.
  • Possess a broad understanding of drug development especially cancer immunotherapy.
  • Ability to collaborate effectively cross-functionally and in a team setting.
  • Excellent interpersonal and written communication skills.
  • Ability to multi-task in a fast-paced dynamic environment.
  • Attention to detail and consistent delivery of high-quality work.


Additional Information

At FivePrime, we believe a diverse workforce drives our success as a company. We are always working to create an environment where different backgrounds and viewpoints are valued and celebrated.

FivePrime is an equal opportunity employer. FivePrime makes employment decisions, including in recruitment and selection, without consideration of race, color, national origin, religion, sex, gender, gender identity or expression, sexual orientation, age, veteran status or disability.

Company

Five Prime Therapeutics, Inc. (NASDAQ: FPRX) is a publicly traded, clinical-stage biotechnology company focused on discovering and developing innovative immuno-oncology protein therapeutics to improve the lives of patients with serious diseases.  We have an industry-leading and differentiated drug discovery platform.  Our comprehensive proprietary libraries of the extracellular proteome, differentiated screening capabilities and protein therapeutic generation and engineering capabilities comprise a unique and powerful IND engine that positions us to discover novel pathways and targets in immuno-oncology and will continue to generate important development programs.  Our success with our drug discovery platform has led to a pipeline that is on track to more than double to five development programs in clinical trials across multiple indications in 2018.  We also have several undisclosed research programs at different points of the target validation and molecule generation phases that have the potential to yield our next wave of development-stage therapeutic biologics.  And we continue to fuel this process at the earliest stages with new screens planned this year.

Five Prime is committed to innovation and outstanding science to develop effective new drugs for the treatment of severe diseases. We value our culture of openness, collaboration and productivity. 

The company is in a strong financial position and has an effective executive team and Board of Directors. Discover more about Five Prime at www.fiveprime.com

Stock Symbol: FPRX

Stock Exchange: Nasdaq

Twitter

Company info
Website
Location
111 Oyster Point Boulevard
San Francisco
California
94080
US

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert